Solid Biosciences Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Charlestown, MA
SLDB chart
What traders are saying about $SLDB
Latest postsSolid Biosciences Inc. news
- H.C. Wainwright reiterates Solid Biosciences stock rating on EU designation
Investing.com ·
- Solid Biosciences Inc. (SLDB) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- A director's wife receives 150,000 stock units in Solid Biosciences (SLDB).
Stock Titan ·
- Solid Biosciences receives EU orphan designation for SGT-212 By Investing.com
Investing.com Nigeria ·
- Solid Biosciences (NASDAQ:SLDB) Gains EU Orphan Designation for SGT-212
Kalkine ·
- Solid Biosciences granted Orphan designation for SGT-212
TipRanks ·
- European Commission grants Orphan status to Solid Biosciences SGT-212 as fifth patient dosed
Traders Union ·
- Solid Biosciences wins EU orphan designation for Friedreich's ataxia therapy
StreetInsider ·
- Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia
Yahoo Finance ·
- Leerink Partners Remains a Buy on Solid Biosciences (SLDB)
The Globe and Mail ·
- Solid Biosciences CMO Gabriel Brooks Vests 9,750 RSUs and Sells 4,374 Shares to Cover Taxes
Kalkine Media ·
- Solid Biosciences to Present Research Across Gene Therapy Development, Delivery and Manufacturing at ESGCT 2026
Yahoo Finance ·
Solid Biosciences Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $8.1M |
| Net income | – | – | – | – |
| Diluted EPS | $-1.99 | $-3.06 | $-4.83 | $-10.10 |
| Total assets (year end) | $232.5M | $188.7M | $164.9M | $260.3M |
| Cash and equivalents (year end) | $59.9M | $80.2M | $74.0M | $155.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Solid Biosciences Inc.
- Ticker
- SLDB (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Charlestown, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1707502
- Former names
- Solid Biosciences, LLC
Frequently asked questions
What exchange is Solid Biosciences Inc. listed on?
Solid Biosciences Inc. trades on the Nasdaq under the ticker symbol SLDB.
What industry is Solid Biosciences Inc. in?
Solid Biosciences Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Solid Biosciences Inc. headquartered?
Solid Biosciences Inc.'s business address on file with the SEC is in Charlestown, MA.
When does Solid Biosciences Inc.'s fiscal year end?
Solid Biosciences Inc.'s fiscal year ends on December 31.
How much revenue did Solid Biosciences Inc. report?
Solid Biosciences Inc. reported $8.1M in revenue for calendar year 2022, according to its SEC filings.